 1. Patients must have an established diagnosis of relapsed or refractory T-cell NHL Eligible histologies include; Peripheral T-cell lymphoma unspecified, CD 30 anaplastic large cell lymphoma ALK-1 positive and ALK-1 negative, angioimmunoblastic T-cell lymphoma, angiocentricnasal type TNK-cell lymphoma, intestinal T-cell lymphoma, hepatosplenic gamma delta T-cell lymphoma, subcutaneous panniculitic T-cell lymphoma, transformed Mycosis fungoides; All patients must have had at last one prior system regimen radiation therapy does not qualify as systemic treatment. 